President Cyril Ramaphosa says the new cancer and Covid-19 vaccine initiative, launched last week, will be a game-changer in South Africa’s fight against Covid-19.
Ramaphosa says the NantAfrica initiative, spearheaded by Dr. Patrick Soon-Shiong, will see the establishment of state-of-the-art vaccine production facilities in the country.
The initiative will also see the launch of the Centre for Epidemic Response and Innovation which will enhance rapid genomic surveillance of and response to viral mutations.
Follow the full briefing here.
Also read more here.
Related articles:
- Patrick Soon-Shiong’s cancer & Covid-19 vaccine initiative to significantly boost South Africa’s vaccine-manufacturing capabilities.
- WHO: Majority of people who get admitted to hospital for Covid-19 complications are unvaccinated.
- Light at the end of the tunnel for South Africa in its fight against Covid-19 pandemic.
[WATCH]: President @CyrilRamaphosa is the guest of honour at an announcement of an initiative ambitious initiative to build capacity for advanced health care in Africa by Dr Patrick Soon-Shiong, founder of the multinational conglomerate, NantWorks LLC. https://t.co/d5s7aq1WR3
— Presidency | South Africa 🇿🇦 (@PresidencyZA) September 23, 2021
Non-human primate study shows protection against SARS-CoV-2 challenge in lung and nasal passages. Special thanks to NIH/NIAID and ASPR/BARDA for their support on this important study. #COVID19 #Vaccine https://t.co/6CwjXonkd4
— ImmunityBio, Inc. (@ImmunityBio) September 17, 2021
